Retatrutide is in Phase 3, the final large-scale trial stage before FDA review
It is still in the clinical trial phase, with more studies going on right now to see how well it works, how safe it is, and what might happen with long-term use
Other presentations, including Wegovy single-dose pens and many Mounjaro or Zepbound single-dose devices, cannot be click-counted at all
The pivotal trials are STEP (semaglutide for weight management, The New England Journal of Medicine , 2021), SURMOUNT (tirzepatide for weight management, NEJM 2022), and SURMOUNT-OSA (tirzepatide for obstructive sleep apnea, NEJM 2024)
That second part matters more than people realize
Pors, Jenny Norlin, Sanne S